Abstract:Abstract Background Coronary microembolization (CME) is a common reason for periprocedural myocardial infarction after coronary interventions. S-nitrosylation (SNO), a prototypic redox-based posttranslational modification, is involved in the pathogenesis of several cardiovascular diseases. Purpose To explore the role of SNO of aconitase-2 (ACO2) in CME-induced cardiac injury, as well as the mechanism by which SNO-ACO2 modulates myocardial injury in response to CME. Methods CME models were established in C57BL/6J mice by injecting 300,000 polyethylene microspheres (diameter 9 µm) into the left ventricle chamber with the occlusion of the ascending aorta. Cardiac function was evaluated by echocardiography. Histological and serum analysis was performed to evaluate myocardial injury. Myocardial samples were scanned for S-nitrosylated proteins using biotin-switch procedures and liquid chromatography with tandem mass spectrometry (LC-MS/MS) analysis. SNO sites of ACO2 were further identified through LC-MS/MS. De-nitrosylation of ACO2 was achieved by the mutation of SNO site or overexpression of the de-nitrosylation enzyme thioredoxin 1 (TRX1). Interacting effectors of SNO- ACO2 were screened through LC-MS/MS and confirmed by coimmunoprecipitation. Neonatal rat ventricular myocytes (NRVMs) were used for in vitro study. The cellular ACO2 activity was analysed using an ACO2 enzyme activity assay kit. Mitochondrial morphology and function were assessed by fluorescent staining and mitochondrial stress testing. Results Cardiac injury was exacerbated by CME as demonstrated by impaired cardiac contractile function, morphological changes, and increased fibrosis, microinfarct size and serum troponin I level. We identified 789 S-nitrosylated proteins in CME mouse hearts, and ACO2 is one of the highly S-nitrosylated proteins. The increased level of SNO-ACO2 was verified by immunoblot assay in CME mouse hearts and hypoxia-stimulated NRVMs. SNO site of ACO2 at cysteine 126 was identified by LC-MS/MS and confirmed in NRVMs. De-nitrosylation of ACO2 by the mutation of cysteine 126 or overexpression of TRX1 both greatly improved the activity of ACO2 by 39.7% and 31.4% respectively, furthermore restored the mitochondrial function, and attenuated CME-induced cardiac injury. Mechanistically, SNO-ACO2 at cysteine 126 suppressed the interaction between ACO2 and NFU1, an iron-sulfur (Fe-S) cluster scaffold protein. The dissociation from NFU1 deprived ACO2 of the Fe-S cluster and the enzyme activity, thereby promoting the disruption of the mitochondrial tricarboxylic acid cycle and cardiac injury. Conclusions Our data defined a previously unrecognized role of SNO-ACO2 in CME-induced cardiac injury. We demonstrated that SNO-ACO2 at cysteine 126 disrupted ACO2/NFU1 interaction to exacerbate myocardial injury after CME. Our results suggested that de-nitrosylation of ACO2 may provide a new therapeutic target for the treatment of CME.

Abstract 4146997: S-nitrosylation of Aconitase-2 Facilitates Coronary Microembolization-induced Cardiac Injury by Suppressing Iron-sulfur Cluster Assembly

S-nitrosylation of Aconitase-2 Facilitates Coronary Microembolization-Induced Cardiac Injury by Suppressing Iron-Sulfur Cluster Assembly

S-nitrosylation of AMPKγ impairs coronary collateral circulation and disrupts VSMC reprogramming

S-nitrosylation of C-Jun N-terminal Kinase Mediates Pressure Overload-Induced Cardiac Dysfunction and Fibrosis

S-Nitrosylation of Septin2 Exacerbates Aortic Aneurysm and Dissection by Coupling the TIAM1-RAC1 Axis in Macrophages.

Resin-Assisted Capture Methods Show That S-Nitrosylation Exerts Cardioprotection During Ischemia/Reperfusion Injury by Directly Reducing Cysteine Oxidation

Postconditioning leads to an increase in protein S-nitrosylation

Nitric Oxide Inhibits Endothelial Cell Apoptosis by Inhibiting Cysteine‐dependent SOD1 Monomerization

The Protective Roles of Nitric Oxide and Superoxide Dismutase in Adriamycin-Induced Cardiotoxicity

Regulation of the Ischemia-Induced Autophagy-Lysosome Processes by Nitrosative Stress in Endothelial Cells.

Soluble Epoxide Hydrolase Activation by S-nitrosation Contributes to Cardiac Ischemia-Reperfusion Injury.

Nicorandil protects against coronary microembolization-induced myocardial injury by suppressing cardiomyocyte pyroptosis via the AMPK/TXNIP/NLRP3 signaling pathway

Myocardial protection of S-nitroso-L-cysteine in diabetic cardiomyopathy mice

Simultaneous Measurement of Protein Oxidation and S-Nitrosylation During Preconditioning and Ischemia/Reperfusion Injury with Resin-Assisted Capture

Molecular Signature of Nitroso-Redox Balance in Idiopathic Dilated Cardiomyopathies

S-Nitrosylation of Histone Deacetylase 2 by Neuronal Nitric Oxide Synthase as a Mechanism of Diastolic Dysfunction

Inhibition of Nitrosative Stress Attenuates Myocardial Injury and Improves Outcomes after Cardiac Arrest and Resuscitation

Dysregulation of Nitrosylation Dynamics Promotes Nitrosative Stress and Contributes to Cardiometabolic Heart Failure with Preserved Ejection Fraction

Protective effects of cysteine analogues on acute myocardial ischemia: Novel modulators of endogenous H2S production

S-nitrosylation of Hsp90 promotes cardiac hypertrophy in mice through GSK3β signaling

Red blood cell eNOS is cardioprotective in acute myocardial infarction